215 related articles for article (PubMed ID: 22123870)
41. Perfusion index variability in preterm infants treated with two different natural surfactants for respiratory distress syndrome.
Karadag N; Dilli D; Zenciroglu A; Aydin B; Beken S; Okumus N
Am J Perinatol; 2014 Nov; 31(11):1015-22. PubMed ID: 24566756
[TBL] [Abstract][Full Text] [Related]
42. Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis.
Qiu C; Ma C; Fan N; Zhang X; Zheng G
Arch Med Sci; 2023; 19(5):1446-1453. PubMed ID: 37732036
[TBL] [Abstract][Full Text] [Related]
43. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
44. Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.
Rey-Santano C; Mielgo VE; Gomez-Solaetxe MA; Bianco F; Salomone F; Loureiro B
Crit Care Med; 2020 Jun; 48(6):e523-e531. PubMed ID: 32301841
[TBL] [Abstract][Full Text] [Related]
45. Goat lung surfactant for treatment of respiratory distress syndrome among preterm neonates: a multi-site randomized non-inferiority trial.
Jain K; Nangia S; Ballambattu VB; Sundaram V; Sankar MJ; Ramji S; Vishnubhatla S; Thukral A; Gupta YK; Plakkal N; Sundaram M; Jajoo M; Kumar P; Jayaraman K; Jain A; Saili A; Murugesan A; Chawla D; Murki S; Nanavati R; Rao S; Vaidya U; Mehta A; Arora K; Mondkar J; Arya S; Bahl M; Utture A; Manerkar S; Bhat SR; Parikh T; Kumar M; Bajpai A; Sivanandan S; Dhawan PK; Vishwakarma G; Bangera S; Kumar S; Gopalakrishnan S; Jindal A; Natarajan CK; Saini A; Karunanidhi S; Malik M; Narang P; Kaur G; Yadav CP; Deorari A; Paul VK; Agarwal R
J Perinatol; 2019 Sep; 39(Suppl 1):3-12. PubMed ID: 31485014
[TBL] [Abstract][Full Text] [Related]
46. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633.
Ricci F; Murgia X; Razzetti R; Pelizzi N; Salomone F
Pediatr Res; 2017 Feb; 81(2):369-375. PubMed ID: 27973472
[TBL] [Abstract][Full Text] [Related]
48. Comparative effectiveness of calfactant and beractant in neonatal respiratory distress syndrome: A systemic review and meta-analysis.
Haider S; Azhar N; Zahid M; Iqbal K; Shoaib N; Irshad N; Siddiqui AS; Ahmed J
Pediatr Pulmonol; 2022 Dec; 57(12):2928-2936. PubMed ID: 36097672
[TBL] [Abstract][Full Text] [Related]
49. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
Halliday HL
Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
[TBL] [Abstract][Full Text] [Related]
50. Pulmonary distribution of lucinactant and poractant alfa and their peridosing hemodynamic effects in a preterm lamb model of respiratory distress syndrome.
Terry MH; Merritt TA; Harding B; Schroeder H; Merrill-Henry J; Mazela J; Gregory TJ; Segal R; Power GG; Blood AB
Pediatr Res; 2010 Sep; 68(3):193-8. PubMed ID: 20531255
[TBL] [Abstract][Full Text] [Related]
51. Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review.
Magni T; Ragni C; Pelizzi N; Sharma S; Perez-Kempner L; Turkstra E; Nathani J; Orlovic M; Meshchenkova N
Pharmacoecon Open; 2023 May; 7(3):359-371. PubMed ID: 36906631
[TBL] [Abstract][Full Text] [Related]
52.
Ricci F; Salomone F; Kuypers E; Ophelders D; Nikiforou M; Willems M; Krieger T; Murgia X; Hütten M; Kramer BW; Bianco F
Front Pediatr; 2017; 5():186. PubMed ID: 28913327
[TBL] [Abstract][Full Text] [Related]
53. Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies.
Królak-Olejnik B; Hożejowski R; Szczapa T
Front Pediatr; 2020; 8():603716. PubMed ID: 33330292
[No Abstract] [Full Text] [Related]
54. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
[TBL] [Abstract][Full Text] [Related]
55. Pumactant and poractant alfa in respiratory distress syndrome.
Wardhaugh AD; Matthes JW
Lancet; 2000 Aug; 356(9231):765-6. PubMed ID: 11085711
[No Abstract] [Full Text] [Related]
56. A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.
Guardia CG; Moya FR; Sinha S; Simmons PD; Segal R; Greenspan JS
J Pediatr Pharmacol Ther; 2012 Jul; 17(3):220-7. PubMed ID: 23258964
[TBL] [Abstract][Full Text] [Related]
57. Exogenous surfactant use in neonates.
Ishisaka DY
Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
[TBL] [Abstract][Full Text] [Related]
58. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome.
Sweet DG; Turner MA; Straňák Z; Plavka R; Clarke P; Stenson BJ; Singer D; Goelz R; Fabbri L; Varoli G; Piccinno A; Santoro D; Speer CP
Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F497-F503. PubMed ID: 28465315
[TBL] [Abstract][Full Text] [Related]
59. Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials.
Ramanathan R
J Perinatol; 2009 May; 29 Suppl 2():S38-43. PubMed ID: 19399008
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Different Types of Natural Surfactants by Lung Ultrasound in Respiratory Distress Syndrome.
Bozkaya D; Dizdar EA; Korkut S; Ceran B; Alkan M; Oğuz ŞS
Am J Perinatol; 2021 May; 38(6):590-596. PubMed ID: 31770784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
